Related Literature
PubMED database was searched for articles containing the keywords "alcoholic cirrhosis" AND "abstinence" AND "survival". 68 articles were retrieved on 11/1/17; a majority of which focused on survival rates of liver transplantation patients. Since our patient was not a candidate for liver transplantation due to her active alcohol abuse, these were found to be irrelevant. Several prospective cohort studies were found. A meta-analysis by Xie et al. on seven such cohort studies concludes that alcohol abstinence does improve the survival of patients with alcoholic cirrhosis, but that it takes at least 1.5 years before a statistically significant difference in survival can be observed. After further comparing the study designs of those seven articles, it is necessary to quantify alcohol consumption. M.W. reported having 5 drinks per day, and assuming 14 grams of alcohol in a standard drink, M.W.'s intake was 70g/day. Five of the seven studies set a cut-off of at least 80g/day. [4] [5] [6] [7] [8] Since our patient would not qualify for those studies, we can exclude them. Of the remaining two studies, Powell et al. only specifies that subjects had a history of chronic alcoholism, and Alvarez et al. specifies at least 80g/day in men and 60g/day in women. 3, 9 Furthermore, it is important to distinguish between compensated and decompensated cirrhosis. Our patient's condition is classified as decompensated cirrhosis, because of her symptomatic presentation. Patients with decompensated cirrhosis are found to have significantly lower survival rates compared to those with compensated cirrhosis. 2 Thus, it would be more precise to select a study concentrating on decompensated patients. Damico et al.'s 1986 study mixed compensated and decompensated patients, which would likely produce higher survival rates and decreased impact of abstinence than expected in a purely decompensated population. Alvarez et al. and Soterakis et al. were the only two studies that solely involved decompensated cirrhotic patients. However, the former study is much more recent, following patients from 1998 to 2010, while the latter's 1973 study is more outdated.
A decision was made to critically appraise Alvarez et al.'s 2011 study because of its stringent criteria and exclusion of patients with underlying liver disease such as hepatocellular carcinoma and hepatitis B and C. It was most relevant to our patient context and the clinical question.
Critical Appraisal
The article by Alvarez et al. is a prospective cohort study following 165 patients for 12 years, monitoring the long-term course of alcoholic cirrhosis (AC). Subjects were those hospitalized in University Hospitals in Barcelona between 1998 and 2001. Inclusion criteria were "(1) the possibility of performing a prospective follow-up in the same referral hospital; (2) no known hepatocarcinoma; and (3) age between 18 and 80 years." Cirrhosis was diagnosed by liver biopsy in 15% of subjects, and the rest were diagnosed by means of biochemical and ultrasonographic features, which corresponds with the guidelines set forth by the American Association for the Study of Liver Diseases (AASLD).
11 Decompensated cirrhosis was defined by ascites, hepatic encephalopathy, portal hypertensive gastrointestinal bleeding, severe bacterial infection, and/or severe alcoholic hepatitis. Follow-ups took place at least twice a year in which patients underwent clinical assessment and standard liver biochemical tests. All patients were encouraged to abstain from alcohol. Administrators evaluated abstinence participation by either querying patients and their relatives, or with urine alcohol tests when abuse was suspected. However, the authors do not explicitly define the time frame for abstinence and how relapses may factor in.
A total of 23 clinical and biological variables were analyzed in relation to survival rate. During follow-up, 99 patients practiced abstinence and 66 did not. 116 patients died overall: 93 liver-related and 23 non-liver-related. Overall survival was significantly higher for abstinent patients (78 vs 32 months, p<0.0001). These patients had higher survival rates at 1 year (95% vs 63%), 5 years (61% vs 36%), and 10 years (31% vs 11%) of follow-up, although this difference cannot be considered statistically significant because no statistical testing was performed, hence no p-values. But from a patient's perspective, these differences would likely be considered substantial.
There are several dissimilarities between our 45-year-old female patient and the study subjects, who are 86% male with median age of 56 years and baseline MELD of 13.8. While Alvarez et al. found age and MELD score to be independently correlated with survival, the coefficient of regression for those two categories (1.07, p<0.001 and 1.05, p=0.03, respectively) are drastically lower than that for alcohol use (2.68, p<0.001). So even if age and MELD score may distinguish M.W. from the study population, the influence of abstinence is still applicable to our patient.
Based on the Strength of Recommendation Taxonomy (SORT) criteria, this study is a level 1A study because it is a prospective cohort study with good follow-up. 10 It is important to note that 5% of patients dropped out, which may be low but the authors did not discuss the details of the drop-outs or how they fit in the data, leading to potential reporting bias. Furthermore, the authors did not delineate the characteristics of the two groups; we do not know how the abstinent and drinking groups differ in age, gender, cause of death, etc. This sort of data would be useful; for example, 23 patients died from non-liver-related causes such as accidents but we do not know the distribution, and results could be skewed if all 23 were found in the non-abstinent group. Confirming abstinence is also essential. The authors claim that urine alcohol tests were only performed when "excessive use was suspected." This ambiguity
